1,034
Views
3
CrossRef citations to date
0
Altmetric
Articles

Hematuria induced by combination regorafenib and hyperthermia – a radiation recall effect

, , , , & ORCID Icon
Pages 1185-1188 | Received 14 Oct 2018, Accepted 26 Aug 2019, Published online: 05 Dec 2019

References

  • D’Angio GJ, Farber S, Maddock CL. Potentiation of x-ray effects by actinomycin D. Radiology. 1959;73:175–177.
  • Azria D, Magne N, Zouhair A, et al. Radiation recall: a well recognized but neglected phenomenon. Cancer Treat Rev. 2005;31(7):555–570.
  • Haraldsdottir S, Bertino E, Haglund K, et al. Radiation recall dermatitis with concomitant dabrafenib and pazopanib therapy. JAMA Dermatol. 2016;152(5):587–589.
  • Azad A, Maddison C, Stewart J. Radiation recall dermatitis induced by pazopanib. Onkologie. 2013;36(11):5–6.
  • Oh D, Park HC, Lim HY, et al. Sorafenib-triggered radiation recall dermatitis with a disseminated exanthematous reaction. Radiat Oncol J. 2013;31(3):171–174.
  • Ubukata M, Kamio T, Ohchi T, et al. Radiation recall dermatitis occurring 6 years and 4 months after breast-conserving surgery: a case report. Oncol Lett. 2016;11(5):3071–3074.
  • Wallenborn PA, Postma DS. Radiation recall supraglottitis. A hazard in head and neck chemotherapy. Arch Otolaryngol. 1984;110(9):614–617.
  • Delavan JA, Chino JP, Vinson EN. Gemcitabine-induced radiation recall myositis. Skelet Radiol. 2015;44(3):451–455.
  • Masri SC, Misselt AJ, Dudek A, et al. Radiation recall reaction causing cardiotoxicity. J Cardiovasc Magn Reson. 2014;16(1):25.
  • Schweitzer VG, Juillard GJ, Bajada CL, Parker RG. Radiation recall dermatitis and pneumonitis in a patient treated with paclitaxel. Cancer. 1995;76(6):1069–1072.
  • Nishimoto K, Akise Y, Miyazawa M, et al. A case of severe rectal hemorrhage possibly caused by radiation recall after administration of gemcitabine. Keio J Med. 2016;65(1):16–20.
  • Barlesi F, Tummino C, Tasei AM, et al. Unsuccessful rechallenge with pemetrexed after a previous radiation recall dermatitis. Lung Cancer. 2006;54(3):423–425.
  • Camidge R, Price A. Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol. 2001;59(3):237–245.
  • Lock M, Sinclair K, Welch S, et al. Radiation recall dermatitis due to gemcitabine does not suggest the need to discontinue chemotherapy. Oncol Lett. 2011;2(1):85–90.
  • Peeken JC, Vaupel P, Combs SE. Integrating hyperthermia into modern radiation oncology: what evidence is necessary? Front Oncol. 2017;7:132.
  • Nishimura Y, Murata R, Hiraoka M. Combined effects of an angiogenesis inhibitor (TNP-470) and hyperthermia. Br J Cancer. 1996;73(3):270–274.
  • Lee SY, Lee NR. Positive response of a primary leiomyosarcoma of the breast following salvage hyperthermia and pazopanib. Korean J Intern Med. 2018;33(2):442–445.
  • Frey B, Weiss EM, Rubner Y, et al. Old and new facts about hyperthermia-induced modulations of the immune system. Int J Hyperthermia. 2012;28(6):528–542.
  • Torigoe T, Tamura Y, Sato N. Heat shock proteins and immunity: application of hyperthermia for immunomodulation. Int J Hyperthermia. 2009;25(8):610–616.